ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Second quarter 2006 financial results for Angiotech Pharmaceuticals, Inc. VANCOUVER, Aug. 1 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the second quarter ended June 30, 2006. DATE: Thursday, August 3, 2006 at 11:00 AM (EDT) (8:00 AM Pacific, 9:00 AM Mountain, 10:00 AM Central) Dial information is as follows: North America (toll-free): 1-866-314-4483 International: 1-617-213-8049 Enter passcode: 78153412 A live webcast will be available to all interested parties through Angiotech's website at http://www.angiotech.com/ under the Investor Relations section. A press release announcing Angiotech's financial results will be issued prior to the conference call at approximately 8:00 AM EDT (5:00 AM Pacific, 6:00 AM Mountain, 7:00 AM Central). A replay archive of the conference call will be available until August 10, 2006. Replay archive information is as follows: North America: 1-888-286-8010 International: 1-617-801-6888 Enter passcode: 57578072 About Angiotech Pharmaceuticals Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with 14 facilities in 6 countries and over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at http://www.angiotech.com/. Angiotech(R) is a trademark of Angiotech Pharmaceuticals, Inc. and its subsidiaries. All rights reserved. CONTACT: Analysts and Institutional Investors: Janet Craig, VP, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (416) 997-9006, ; Media and Retail Investors: Jodi Regts, Manager, Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Analysts and Institutional Investors: Janet Craig, VP, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (416) 997-9006, ; Media and Retail Investors: Jodi Regts, Manager, Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930,

Copyright